As of 2025-09-11, the Relative Valuation of Genesis Healthcare Inc (GEN) is 20.79 USD. This relative valuation is based on P/E multiples. With the latest stock price at 29.25 USD, the upside of Genesis Healthcare Inc based on Relative Valuation is -28.9%.
The range of the Relative Valuation is 17.91 - 25.09 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.5x - 25.9x | 21.8x |
| Forward P/E multiples | 16.7x - 19.0x | 18.2x |
| Fair Price | 17.91 - 25.09 | 20.79 |
| Upside | -38.8% - -14.2% | -28.9% |
| Date | P/E |
| 2025-09-10 | 30.17 |
| 2025-09-09 | 30.40 |
| 2025-09-08 | 30.86 |
| 2025-09-05 | 30.43 |
| 2025-09-04 | 30.46 |
| 2025-09-03 | 30.60 |
| 2025-09-02 | 30.43 |
| 2025-08-29 | 31.15 |
| 2025-08-28 | 31.16 |
| 2025-08-27 | 31.71 |
| 2025-08-26 | 31.74 |
| 2025-08-25 | 32.11 |
| 2025-08-22 | 32.58 |
| 2025-08-21 | 32.18 |
| 2025-08-20 | 32.43 |
| 2025-08-19 | 32.50 |
| 2025-08-18 | 32.36 |
| 2025-08-15 | 32.46 |
| 2025-08-14 | 32.51 |
| 2025-08-13 | 33.18 |
| 2025-08-12 | 32.86 |
| 2025-08-11 | 31.74 |
| 2025-08-08 | 31.41 |
| 2025-08-07 | 29.16 |
| 2025-08-06 | 29.60 |
| 2025-08-05 | 29.48 |
| 2025-08-04 | 29.90 |
| 2025-08-01 | 29.70 |
| 2025-07-31 | 30.42 |
| 2025-07-30 | 30.78 |
| 2025-07-29 | 31.23 |
| 2025-07-28 | 31.48 |
| 2025-07-25 | 31.58 |
| 2025-07-24 | 31.48 |
| 2025-07-23 | 31.65 |
| 2025-07-22 | 31.48 |
| 2025-07-21 | 31.25 |
| 2025-07-18 | 31.23 |
| 2025-07-17 | 31.09 |
| 2025-07-16 | 30.97 |
| 2025-07-15 | 30.86 |
| 2025-07-14 | 30.74 |
| 2025-07-11 | 29.60 |
| 2025-07-10 | 30.62 |
| 2025-07-09 | 31.11 |
| 2025-07-08 | 30.89 |
| 2025-07-07 | 31.05 |
| 2025-07-03 | 31.45 |
| 2025-07-02 | 30.75 |
| 2025-07-01 | 30.74 |